STOCK TITAN

atai Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on mental health treatment, will participate in the Cowen 43rd Annual Health Care Conference on March 6, 2023, from 12:50 p.m. to 1:20 p.m. ET. The event format will be a Neuropsych Corporate Panel held in Boston, MA. A live webcast of the panel can be accessed via the atai website, with an archived replay available for 30 days post-event. Founded in 2018, atai is dedicated to innovating therapeutics for mental health disorders, aiming to enhance patient outcomes and transform lives.

Positive
  • None.
Negative
  • None.

NEW YORK and BERLIN, March 01, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the Cowen 43rd Annual Health Care Conference.

Details of the company’s panel participation are as follows:

Cowen 43rd Annual Health Care Conference  

Format: Neuropsych Corporate Panel

Date and Time: Monday, March 6th, 12:50 p.m. – 1:20 p.m. ET

Location: Boston, MA

A live webcast of the panel will be available on atai’s website under Events on the Investors section of the atai website: https://ir.atai.life/news-events/events/. An archived replay of the webcast will be available for up to 30 days following the panel discussion.

About atai Life Sciences

atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, atai is dedicated to acquiring, incubating, and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders.

By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines across its companies to achieve clinically meaningful and sustained behavioral change in mental health patients.

atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life.

Contact Information

Investor Contact:
Stephen Bardin
Chief Financial Officer
IR@atai.life

Media Contact:
Allan Malievsky
Senior Director, External Affairs
PR@atai.life


FAQ

What date will atai Life Sciences participate in the Cowen 43rd Annual Health Care Conference?

atai Life Sciences will participate in the conference on March 6, 2023.

What time is the atai Life Sciences panel at the Cowen Conference?

The atai Life Sciences panel is scheduled from 12:50 p.m. to 1:20 p.m. ET.

Where is the Cowen 43rd Annual Health Care Conference being held?

The conference will take place in Boston, MA.

How can I watch the atai Life Sciences panel discussion?

You can watch the panel discussion live via the atai website under the Events section.

What is the focus of atai Life Sciences?

atai Life Sciences focuses on developing innovative therapeutics for treating mental health disorders.

ATAI Life Sciences N.V. Common Shares

NASDAQ:ATAI

ATAI Rankings

ATAI Latest News

ATAI Stock Data

256.87M
151.01M
9.99%
26.83%
5.62%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BERLIN